Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-16-732699
Filing Date
2016-10-06
Accepted
2016-10-06 16:09:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d257502d424b5.htm 424B5 380526
2 GRAPHIC g257502g23n74.jpg GRAPHIC 14422
  Complete submission text file 0001193125-16-732699.txt   401629
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-211472 | Film No.: 161924974
SIC: 2836 Biological Products, (No Diagnostic Substances)